CNBC - Health
Healthy Returns: What to expect from pharma at the JPM conference
4 hours ago
Europe's best-performing blue-chip stock has become a prime takeover target10 hours ago
Patient advocates urge U.S. court to halt overseas prescription drug operations10 hours ago
CNBC launches CNBC Cures to help 30 million Americans with rare diseases1 day ago
CNBC's Becky Quick details daughter's rare disease journey1 day ago
OpenAI launches ChatGPT Health to connect user medical records, wellness apps2 days ago
RFK Jr. unveils new nutrition guidelines, pushing more protein, less processed food2 days ago
First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.4 days ago
2026 will bring GLP-1 weight loss pills: These stocks will benefit from new habits4 days ago
Lilly investors shouldn't sweat rival Novo having the first obesity pill on sale8 days ago
Wegovy-maker Novo Nordisk shares surge after GLP-1 weight loss pill approval17 days ago
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk17 days ago
The donors, insiders and data behind Trump's marijuana executive order17 days ago
UnitedHealth Group commits to improvements after independent audit results21 days ago
Wall Street banked on a flurry of deals in 2025. It wasn't that simple21 days ago
Trump signs executive order reclassifying weed, opening door to broader access21 days ago
Eli Lilly says obesity pill helps maintain weight loss after Wegovy, Zepbound22 days ago
Medical supply firm Medline jumps more than 40% in debut after biggest IPO of 202523 days ago
Healthy Returns: 2026 will be the year of obesity pills23 days ago
Pfizer's modest 2026 outlook shows its big investments will take time to pay off24 days ago
Trump says he's 'strongly' considering reclassifying pot via executive order25 days ago
Why Wall Street and Jim Cramer think Danaher stock is 'ready to go for a romp'25 days ago
FDA approved a Singapore work trip during government shutdown, records show25 days ago
Healthy Returns: FDA may add its strongest safety warning to Covid vaccines25 days ago
'The next protein': Fiber is shaping up to be the latest grocery obsession28 days ago
Danish drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly28 days ago
Eli Lilly obesity drug delivers weight loss, reduces knee pain in trial29 days ago
Eli Lilly to build $6 billion Alabama manufacturing plant for obesity pill29 days ago
A biotech stock for investors scared to invest in the risky industry1 month ago
FDA approves Merck treatment for decimated U.S. cattle herds to stop screwworm1 month ago
Pfizer adds to obesity bet with up to $2.1 billion deal with Chinese company1 month ago
Bill Gates on why AI will become 'hyper competitive'1 month ago
RFK Jr.'s vaccine panel weakens recommendation on hepatitis B shot for babies1 month ago
RFK Jr.'s vaccine panel defers vote on hepatitis B shot for babies until Friday1 month ago
